Abstract:BACKGROUND:Skeletal muscle mass is determined by the balance between protein synthesis and degradation. Mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of protein translation and has been implicated in the control of muscle mass. Inactivation of mTORC1 by skeletal muscle-specific deletion of its obligatory component raptor results in smaller muscles and a lethal dystrophy. Moreover, raptor-deficient muscles are less oxidative through changes in the expression PGC-1α, a critical determinant of mitochondrial biogenesis. These results suggest that activation of mTORC1 might be beneficial to skeletal muscle by providing resistance to muscle atrophy and increasing oxidative function. Here, we tested this hypothesis by deletion of the mTORC1 inhibitor tuberous sclerosis complex (TSC) in muscle fibers.METHOD:Skeletal muscles of mice with an acute or a permanent deletion of raptor or TSC1 were examined using histological, biochemical and molecular biological methods. Response of the muscles to changes in mechanical load and nerve input was investigated by ablation of synergistic muscles or by denervation .RESULTS:Genetic deletion or knockdown of raptor, causing inactivation of mTORC1, was sufficient to prevent muscle growth and enhance muscle atrophy. Conversely, short-term activation of mTORC1 by knockdown of TSC induced muscle fiber hypertrophy and atrophy-resistance upon denervation, in both fast tibialis anterior (TA) and slow soleus muscles. Surprisingly, however, sustained activation of mTORC1 by genetic deletion of Tsc1 caused muscle atrophy in all but soleus muscles. In contrast, oxidative capacity was increased in all muscles examined. Consistently, TSC1-deficient soleus muscle was atrophy-resistant whereas TA underwent normal atrophy upon denervation. Moreover, upon overloading, plantaris muscle did not display enhanced hypertrophy compared to controls. Biochemical analysis indicated that the atrophy response of muscles was based on the suppressed phosphorylation of PKB/Akt via feedback inhibition by mTORC1 and subsequent increased expression of the E3 ubiquitin ligases MuRF1 and atrogin-1/MAFbx. In contrast, expression of both E3 ligases was not increased in soleus muscle suggesting the presence of compensatory mechanisms in this muscle.CONCLUSIONS:Our study shows that the mTORC1- and the PKB/Akt-FoxO pathways are tightly interconnected and differentially regulated depending on the muscle type. These results indicate that long-term activation of the mTORC1 signaling axis is not a therapeutic option to promote muscle growth because of its strong feedback induction of the E3 ubiquitin ligases involved in protein degradation.

ERK1/2 Signaling Induces Skeletal Muscle Slow Fiber-Type Switching and Reduces Muscular Dystrophy Disease Severity

ERK/MAPK Signaling Is Required for Pathway-Specific Striatal Motor Functions

The Merg1a Channel Modulates Skeletal Muscle Murf1, but Not Mafbx, Expression

SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy

The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis

Extracellular Signal–Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway is Involved in Myostatin-Regulated Differentiation Repression

CaMKK2 Suppresses Muscle Regeneration Through the Inhibition of Myoblast Proliferation and Differentiation

The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity.

BDNF is a mediator of glycolytic fiber-type specification in mouse skeletal muscle

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse

Differential Response of Skeletal Muscles to Mtorc1 Signaling During Atrophy and Hypertrophy

ULK2 Regulates p62‐ and NBR1‐Dependent Selective Autophagy In Skeletal Muscle

Abstract 9576: A Nuclear Receptor-microRNA Circuit Links Control of Muscle Fiber Type to Energy Metabolism

RSK2 Mediates Muscle Cell Differentiation Through Regulation of NFAT3.

Dynamic m6A mRNA Methylation Reveals the Role of METTL3/14-m6A-MNK2-ERK Signaling Axis in Skeletal Muscle Differentiation and Regeneration

Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy

Myostatin inhibition promotes fast fibre hypertrophy but causes loss of AMP-activated protein kinase signalling and poor exercise tolerance in a model of limb-girdle muscular dystrophy R1/2A

Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy

mTORC1 mediates fiber type-specific regulation of protein synthesis and muscle size during denervation

Relationships between endurance exercise training-induced muscle fiber-type shifting and autophagy in slow- and fast-twitch skeletal muscles of mice

Myofibre-specific knockout of TGF-β type I receptors triggers muscle hypertrophy and promotes contraction and oxidative metabolism